Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MedVadis Research is a leading independent clinical trial center specializing in neurology and pain management. It has conducted over 300 clinical trials since 1996, including pivotal studies for drugs such as Imitrex®, Zomig®, Botox®, Topamax®, Amitiza®, and Nucynta®. The company has contributed to the development of new treatments for chronic pain, headache disorders, and other neurological and internal medicine conditions[1][5]. Notably, it participated in studies evaluating intranasal oxytocin for chronic daily headache and extended-release oxymorphone for cognitive effects in opioid-tolerant subjects[2].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MedVadis Research.